albuterol has been researched along with Facio-Scapulo-Humeral Dystrophy in 6 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pain and fatigue are important features in FSHD." | 6.73 | Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy. ( Bleijenberg, G; Hendriks, JC; Kalkman, JS; Lindeman, E; Padberg, GW; van der Kooi, EL; van Engelen, BG, 2007) |
| "Albuterol was well tolerated; side effects included cramps, tremors, insomnia, and nervousness." | 6.70 | Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy. ( Griggs, RC; King, WM; Kissel, JT; McDermott, MP; Mendell, JR; Pandya, S; Tawil, R, 2001) |
| "Salbutamol (sustained released formulation) administered orally at a daily dose of 16 mg using a periodic dosage regimen (3 wks on, 1 wk off)." | 2.74 | Periodic salbutamol in facioscapulohumeral muscular dystrophy: a randomized controlled trial. ( Attarian, S; Desnuelle, C; Doppler, V; Eymard, B; Hammouda, EH; Hogrel, JY; Lacomblez, L; Laforêt, P; Ollivier, G; Payan, CA; Pouget, J, 2009) |
| "Pain and fatigue are important features in FSHD." | 2.73 | Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy. ( Bleijenberg, G; Hendriks, JC; Kalkman, JS; Lindeman, E; Padberg, GW; van der Kooi, EL; van Engelen, BG, 2007) |
| "In patients with facioscapulohumeral muscular dystrophy (FSHD) albuterol may exert anabolic effects." | 2.71 | Strength training and albuterol in facioscapulohumeral muscular dystrophy. ( Hendriks, JC; Lindeman, E; Padberg, GW; van Asseldonk, RJ; van der Kooi, EL; van der Maarel, SM; Vogels, OJ; Wohlgemuth, M, 2004) |
| "Albuterol was well tolerated; side effects included cramps, tremors, insomnia, and nervousness." | 2.70 | Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy. ( Griggs, RC; King, WM; Kissel, JT; McDermott, MP; Mendell, JR; Pandya, S; Tawil, R, 2001) |
| "Creatine has been used as a muscle performance enhancer by athletes and it might be helpful in muscular dystrophies including facioscapulohumeral muscular dystrophy." | 2.42 | Drug treatment for facioscapulohumeral muscular dystrophy. ( Rose, MR; Tawil, R, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Payan, CA | 1 |
| Hogrel, JY | 1 |
| Hammouda, EH | 1 |
| Lacomblez, L | 1 |
| Ollivier, G | 1 |
| Doppler, V | 1 |
| Eymard, B | 1 |
| Attarian, S | 1 |
| Pouget, J | 1 |
| Desnuelle, C | 1 |
| Laforêt, P | 1 |
| Rose, MR | 1 |
| Tawil, R | 2 |
| van der Kooi, EL | 2 |
| Vogels, OJ | 1 |
| van Asseldonk, RJ | 1 |
| Lindeman, E | 2 |
| Hendriks, JC | 2 |
| Wohlgemuth, M | 1 |
| van der Maarel, SM | 1 |
| Padberg, GW | 2 |
| Kalkman, JS | 1 |
| van Engelen, BG | 1 |
| Bleijenberg, G | 1 |
| Nakagawa, M | 1 |
| Higuchi, I | 1 |
| Kissel, JT | 1 |
| McDermott, MP | 1 |
| Mendell, JR | 1 |
| King, WM | 1 |
| Pandya, S | 1 |
| Griggs, RC | 1 |
2 reviews available for albuterol and Facio-Scapulo-Humeral Dystrophy
| Article | Year |
|---|---|
Drug treatment for facioscapulohumeral muscular dystrophy.
Topics: Adrenergic beta-Agonists; Albuterol; Creatine; Humans; Muscular Dystrophy, Facioscapulohumeral; Rand | 2004 |
[Facioscapulohumeral muscular dystrophy].
Topics: Adrenergic beta-Agonists; Albuterol; Chromosomes, Human, Pair 4; Deoxyribonucleases, Type II Site-Sp | 2001 |
4 trials available for albuterol and Facio-Scapulo-Humeral Dystrophy
| Article | Year |
|---|---|
Periodic salbutamol in facioscapulohumeral muscular dystrophy: a randomized controlled trial.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Blood Pressure; Delayed-Action Preparations; | 2009 |
Strength training and albuterol in facioscapulohumeral muscular dystrophy.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Ankle Joint; Combined Modality Therapy; Delayed-Action P | 2004 |
Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Combined Modality Therapy; Double-Blind Method; Exercise | 2007 |
Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Body Mass Index; Double-Blind Method; Female; Hand Stren | 2001 |